Latest News

Under Trump, FDA seeks to abandon expert reviews of new drugs

todaySeptember 12, 2025

share close
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny.

FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny.

Written by:

Rate it

Previous post

In meeting with RFK Jr., CEO of Tylenol maker stresses there is no clear link between medication and autism, WSJ reports

Latest News

In meeting with RFK Jr., CEO of Tylenol maker stresses there is no clear link between medication and autism, WSJ reports

The interim CEO and director of drugmaker Kenvue, which makes the common pain reliever Tylenol, met with US Health and Human Services Secretary Robert F. Kennedy Jr. privately this week in an attempt to dissuade him from including the drug as a potential cause of autism in an upcoming report, the Wall Street Journal reported Friday.The interim CEO and director of drugmaker Kenvue, which makes the common pain reliever Tylenol, […]

todaySeptember 12, 2025

Post comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *

0%